ProSolus Revenue and Competitors
Estimated Revenue & Valuation
- ProSolus's estimated annual revenue is currently $2.6M per year.
- ProSolus's estimated revenue per employee is $201,000
Employee Data
- ProSolus has 13 Employees.
- ProSolus grew their employee count by 0% last year.
ProSolus's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP MFG Operations | Reveal Email/Phone |
2 | Chief Scientific Officer | Reveal Email/Phone |
3 | Director | Reveal Email/Phone |
ProSolus Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $26.5M | 132 | N/A | N/A | N/A |
#2 | $10.1M | 50 | 14% | N/A | N/A |
#3 | $282.6M | 1406 | N/A | N/A | N/A |
#4 | $13.9M | 69 | 44% | N/A | N/A |
#5 | $11.3M | 56 | 4% | N/A | N/A |
#6 | $11.5M | 57 | -7% | N/A | N/A |
#7 | $211.7M | 1072 | 4% | N/A | N/A |
#8 | $24.1M | 120 | 5% | N/A | N/A |
#9 | $7.8M | 39 | -2% | N/A | N/A |
#10 | $12.9M | 64 | -2% | N/A | N/A |
What Is ProSolus?
ProSolus Pharmaceuticals delivers sophisticated transdermal solutions customized to meet your needs and exceed your expectations. We formulate, develop, and manufacture high-barrier-to-entry transdermal drug delivery products in our state-of-the-art laboratories and manufacturing facility. Our patches are designed with the patient in mind. ProSolus Pharmaceuticals is an experienced partner with unrivaled transdermal prowess. Our experts are committed to delivering a customized experience every step of the way concept through completion. Whether you need formulation, development, and/or manufacturing support, we'll provide sophisticated solutions tailored to your needs. Our research and development team works collaboratively with strategic suppliers to create polymers and design combinations of excipients that improve the absorption of medications through the skin without having to resort to exotic permeation enhancers. Focused on what lies ahead, our team continues to explore methods to optimize transdermal drug delivery.
keywords:N/A
N/A
Total Funding
13
Number of Employees
$2.6M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ProSolus News
AdhexPharma, ProSolus, Inc., Tapemark, Tesa Labtec GmbH, Nitto Denko Corporation, Noven Pharmaceuticals, Inc. LTS Lohmann, Therapie-Systeme AG,...
Inc.), Prosolus Inc., Samyang Holdings Corporation, Tapemark, Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd), tesa SE (Beiersdorf AG) and...
ProSolus is the new jewel in Mission's crown as a manufacturing supplier, said Pete Valko, chief operating officer, ProSolus Inc., who is...
Other Companies in Miami
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.8M | 13 | N/A | N/A |
#2 | $0.9M | 13 | 0% | N/A |
#3 | $2M | 13 | 8% | N/A |
#4 | $1M | 13 | 8% | N/A |
#5 | $15M | 13 | 18% | N/A |